Back to Speakers
Georgina Hold obtained her PhD degree from the Division of Infection and Immunity at the University of Glasgow. She is a leading authority on emerging Campylobacter and their role in intestinal disease and in 2014, was awarded a scholarship to Harvard T. H. Chan School of Public Health to study emerging Campylobacter organisms. She currently leads a pioneering Australian IBD Microbiome study looking at how gut microbes, diet and environmental factors affect IBD and IBD treatment responses. Professor Hold is also the president of the European Helicobacter Microbiota Study Group.
CLINICAL PHARMACY UPDATE: Gut health, probiotics and improving immune health - what do we know?
Friday 20 March, 11:00am - 11:30am
Proudly sponsored by:
SPONSOR AND TRADE
(c) 2021 APP Conference 2022. All Rights Reserved.
The Pharmacy Guild of Australia
07 3831 9246
07 3831 3788
© 2022 APP Conference. All Rights Reserved.
The 2022 Australian Pharmacy Professional Conference is proudly sponsored by:
TERMS AND CONDITIONS
APP Sand 1
APP OCEAN 3
APP OCEAN 2